Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice

MLA

Chen, Pu-Guang, et al. “Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice.” Molecular Pharmaceutics, vol. 17, no. 2, Feb. 2020, pp. 417–25. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.9b00720.

APA

Chen, P.-G., Hu, H.-G., Sun, Z.-Y., Li, Q.-Q., Zhang, B.-D., Wu, J.-J., Li, W.-H., Zhao, Y.-F., Chen, Y.-X., & Li, Y.-M. (2020). Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice. Molecular Pharmaceutics, 17(2), 417–425. https://doi.org/10.1021/acs.molpharmaceut.9b00720

Chicago

Chen, Pu-Guang, Hong-Guo Hu, Zhan-Yi Sun, Qian-Qian Li, Bo-Dou Zhang, Jun-Jun Wu, Wen-Hao Li, Yu-Fen Zhao, Yong-Xiang Chen, and Yan-Mei Li. 2020. “Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice.” Molecular Pharmaceutics 17 (2): 417–25. doi:10.1021/acs.molpharmaceut.9b00720.